536 related articles for article (PubMed ID: 17020942)
1. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M; Sureau C
J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
[TBL] [Abstract][Full Text] [Related]
2. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
Jenna S; Sureau C
Virology; 1998 Nov; 251(1):176-86. PubMed ID: 9813213
[TBL] [Abstract][Full Text] [Related]
3. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.
Abou-Jaoudé G; Sureau C
J Virol; 2007 Dec; 81(23):13057-66. PubMed ID: 17898062
[TBL] [Abstract][Full Text] [Related]
4. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
Jaoudé GA; Sureau C
J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
[TBL] [Abstract][Full Text] [Related]
5. A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles.
Komla-Soukha I; Sureau C
J Virol; 2006 May; 80(10):4648-55. PubMed ID: 16641257
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus assembly is sensitive to changes in the cytosolic S loop of the envelope proteins.
Löffler-Mary H; Dumortier J; Klentsch-Zimmer C; Prange R
Virology; 2000 May; 270(2):358-67. PubMed ID: 10792995
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
[TBL] [Abstract][Full Text] [Related]
8. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.
Julithe R; Abou-Jaoudé G; Sureau C
J Virol; 2014 Aug; 88(16):9049-59. PubMed ID: 24899172
[TBL] [Abstract][Full Text] [Related]
9. N-linked glycosylation of hepatitis B surface antigens is involved but not essential in the assembly of hepatitis delta virus.
Wang CJ; Sung SY; Chen DS; Chen PJ
Virology; 1996 Jun; 220(1):28-36. PubMed ID: 8659125
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
[TBL] [Abstract][Full Text] [Related]
11. Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle.
Poisson F; Severac A; Hourioux C; Goudeau A; Roingeard P
Virology; 1997 Feb; 228(1):115-20. PubMed ID: 9024817
[TBL] [Abstract][Full Text] [Related]
12. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.
Gripon P; Le Seyec J; Rumin S; Guguen-Guillouzo C
Virology; 1995 Nov; 213(2):292-9. PubMed ID: 7491754
[TBL] [Abstract][Full Text] [Related]
13. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
14. Assembly of hepatitis delta virus particles: package of multimeric hepatitis delta virus genomic RNA and role of phosphorylation.
Yeh TS; Lee YH
Virology; 1998 Sep; 249(1):12-20. PubMed ID: 9740772
[TBL] [Abstract][Full Text] [Related]
15. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.
Sureau C; Fournier-Wirth C; Maurel P
J Virol; 2003 May; 77(9):5519-23. PubMed ID: 12692255
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the carboxyl-terminal domain of the small hepatitis B virus envelope protein impair the assembly of hepatitis delta virus particles.
Jenna S; Sureau C
J Virol; 1999 Apr; 73(4):3351-8. PubMed ID: 10074189
[TBL] [Abstract][Full Text] [Related]
17. Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.
Ning X; Luckenbaugh L; Liu K; Bruss V; Sureau C; Hu J
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743374
[TBL] [Abstract][Full Text] [Related]
18. Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants.
Billioud G; Pichoud C; Parent R; Zoulim F
J Hepatol; 2012 Jun; 56(6):1269-75. PubMed ID: 22314422
[TBL] [Abstract][Full Text] [Related]
19. A unique amino acid substitution, L215Q, in the hepatitis B virus small envelope protein of a genotype F isolate that inhibits secretion of hepatitis B virus subviral particles.
Araujo NM; Vianna CO; Soares CC; Gomes SA
Intervirology; 2008; 51(2):81-6. PubMed ID: 18434744
[TBL] [Abstract][Full Text] [Related]
20. Myristoylation signal transfer from the large to the middle or the small HBV envelope protein leads to a loss of HDV particles infectivity.
Abou-Jaoudé G; Molina S; Maurel P; Sureau C
Virology; 2007 Aug; 365(1):204-9. PubMed ID: 17462692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
